Stay updated on Durvalumab/Olaparib Combo in Triple-Negative Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the Durvalumab/Olaparib Combo in Triple-Negative Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Durvalumab/Olaparib Combo in Triple-Negative Breast Cancer Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The footer revision number changes from v3.7.0 to v3.7.1 while the page continues to show a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-11T01:51:06.000Z thumbnail image
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    No Change Detected
  4. Check
    23 days ago
    Change Detected
    Summary
    The study page now loads as a 403 Forbidden error, replacing the expected study record with an access-restricted page.
    Difference
    19%
    Check dated 2026-09-20T00:32:25.000Z thumbnail image
  5. Check
    44 days ago
    Change Detected
    Summary
    Revision label updated from v3.6.5 to v3.6.6 on the page, indicating a new build of the site hosting the record. This update does not modify study details, eligibility criteria, or results and likely reflects a minor backend/UI improvement.
    Difference
    0.1%
    Check dated 2026-08-29T20:40:36.000Z thumbnail image
  6. Check
    66 days ago
    Change Detected
    Summary
    Page revision changed from v3.6.4 to v3.6.5, indicating a small administrative update to the page. This update does not modify the study data or other visible content.
    Difference
    0.1%
    Check dated 2026-08-08T18:25:55.000Z thumbnail image
  7. Check
    80 days ago
    Change Detected
    Summary
    Adds the updated document revision v3.6.4 for the study materials and removes the older v3.6.3 version. This reflects an updated protocol and related materials associated with the study on ClinicalTrials.gov.
    Difference
    0.1%
    Check dated 2026-07-25T10:40:21.000Z thumbnail image
  8. Check
    101 days ago
    Change Detected
    Summary
    Revision: v3.6.3 was added, indicating an updated version of the Study Protocol and Statistical Analysis Plan document. The previous revision (v3.6.2) was removed.
    Difference
    0.1%
    Check dated 2026-07-03T22:25:01.000Z thumbnail image

Stay in the know with updates to Durvalumab/Olaparib Combo in Triple-Negative Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Durvalumab/Olaparib Combo in Triple-Negative Breast Cancer Clinical Trial page.